We partner with the most successful and talented entrepreneurs within the MedTech industry. From experienced management teams returning with new technologies to first time entrepreneurs with innovative concepts, we build the future of healthcare together.
CHV has produced a successful track record utilizing an investment strategy specifically for early-stage MedTech investing. We invest in companies that are:
Typically first institutional investor; supporting companies during the scientific, clinical, regulatory, and commercial stages.
We focus on medical device, medical technology, diagnostics, and sometimes digital health. We do not invest in biotech or pharma.
Products with large global markets where there is a significant unmet clinical need. Often times where drugs do not work.
The Catalyst Health Ventures team brings passion for MedTech investing backed with a successful track record of building companies. Our investment professionals and advisors have invaluable experience, resources, and a connected network to support our early stage portfolio companies.
The latest news and updates from CHV